598 related articles for article (PubMed ID: 19054674)
1. Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):481-4. PubMed ID: 19054674
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.
Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV
Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria.
Rasoanaivo P; Ratsimamanga-Urverg S; Milijaona R; Rafatro H; Rakoto-Ratsimamanga A; Galeffi C; Nicoletti M
Planta Med; 1994 Feb; 60(1):13-6. PubMed ID: 8134408
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
Biot C; Glorian G; Maciejewski LA; Brocard JS
J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
[TBL] [Abstract][Full Text] [Related]
6. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
Manohar S; Khan SI; Rawat DS
Chem Biol Drug Des; 2013 May; 81(5):625-30. PubMed ID: 23331618
[TBL] [Abstract][Full Text] [Related]
7. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.
Sanchez CP; Stein WD; Lanzer M
Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873
[TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of 7-benzylamino-1-isoquinolinamines against Plasmodium falciparum related to the efficacy of chalcones.
Gutteridge CE; Hoffman MM; Bhattacharjee AK; Milhous WK; Gerena L
Bioorg Med Chem Lett; 2011 Jan; 21(2):786-9. PubMed ID: 21168330
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-chloroquine analogues.
Cunico W; Cechinel CA; Bonacorso HG; Martins MA; Zanatta N; de Souza MV; Freitas IO; Soares RP; Krettli AU
Bioorg Med Chem Lett; 2006 Feb; 16(3):649-53. PubMed ID: 16257205
[TBL] [Abstract][Full Text] [Related]
10. Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores.
Sashidhara KV; Kumar M; Modukuri RK; Srivastava RK; Soni A; Srivastava K; Singh SV; Saxena JK; Gauniyal HM; Puri SK
Bioorg Med Chem; 2012 May; 20(9):2971-81. PubMed ID: 22464685
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
[TBL] [Abstract][Full Text] [Related]
12. Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
Blackie MA; Beagley P; Croft SL; Kendrick H; Moss JR; Chibale K
Bioorg Med Chem; 2007 Oct; 15(20):6510-6. PubMed ID: 17693090
[TBL] [Abstract][Full Text] [Related]
13. Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6.
Navarro M; Pérez H; Sánchez-Delgado RA
J Med Chem; 1997 Jun; 40(12):1937-9. PubMed ID: 9191972
[No Abstract] [Full Text] [Related]
14. A primaquine-chloroquine hybrid with dual activity against Plasmodium liver and blood stages.
Lödige M; Lewis MD; Paulsen ES; Esch HL; Pradel G; Lehmann L; Brun R; Bringmann G; Mueller AK
Int J Med Microbiol; 2013 Dec; 303(8):539-47. PubMed ID: 23992634
[TBL] [Abstract][Full Text] [Related]
15. The bioactivity of novel furanoterpenoids isolated from Siphonochilus aethiopicus.
Lategan CA; Campbell WE; Seaman T; Smith PJ
J Ethnopharmacol; 2009 Jan; 121(1):92-7. PubMed ID: 18996179
[TBL] [Abstract][Full Text] [Related]
16. A clinical drug library screen identifies astemizole as an antimalarial agent.
Chong CR; Chen X; Shi L; Liu JO; Sullivan DJ
Nat Chem Biol; 2006 Aug; 2(8):415-6. PubMed ID: 16816845
[TBL] [Abstract][Full Text] [Related]
17. Dual-acting diamine antiplasmodial and chloroquine resistance modulating agents.
Yeh S; Smith PJ; Chibale K
Biochem Pharmacol; 2006 Jul; 72(2):156-65. PubMed ID: 16730664
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine resistant falciparum malaria--the Indian scene.
Chogle AR
J Assoc Physicians India; 1996 Oct; 44(10):677-8. PubMed ID: 9251337
[No Abstract] [Full Text] [Related]
20. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H
Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
